Access and Autonomy with Opill (featuring Dr. Stephanie Sober)
Description
Access to contraception can shape health, autonomy, and opportunity, but what does it really take to safely expand that access? In this episode, we’re joined by Dr. Stephanie Sober, OB-GYN and Global Director of Medical Affairs at Perrigo Women’s Health, to explore the landmark approval of Opill, the first daily oral contraceptive available over the counter in the U.S. Tune in to hear how nearly a decade of research and regulatory work made this switch possible, how the FDA evaluates real-world use without physician supervision, and why over-the-counter contraception is a major step forward for reproductive health equity.
Dr. Stephanie Sober is an OB-GYN physician and the Global Director of Medical Affairs at Perrigo Women’s Health. She co-led the studies submitted to the FDA to support Opill’s transition from prescription-only to over-the-counter status and has worked closely with medical organizations, regulators, and reproductive health advocates to expand safe, evidence-based access to contraception.
United States
